DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 02 · Volume 35 · March 2002 DOI: 10.1055/s-002-1702

Original Paper

37
Gaertner, I.; Gilot, C.; Heidrich, P.; Gaertner, H.-J.: A Case Control Study on Psychopharmacotherapy before Suicide Committed by 61 Psychiatric Inpatients
44
Müller-Oerlinghausen, B.; Roggenbach, J.: Concretism in Biological Suicide Research - Are We Eating the Menu Instead of the Meal?
50
Bondolfi, G.; Eap, C. B.; Bertschy, G.; Zullino, D.; Vermeulen, A.; Baumann, P.: The Effect of Fluoxetine on the Pharmacokinetics and Safety of Risperidone in Psychotic Patients
57
Müller-Vahl, K. R.; Schneider, U.; Koblenz, A.; Jöbges, M.; Kolbe, H.; Daldrup, T.; Emrich, H. M.: Treatment of Tourette's Syndrome with Δ9-Tetrahydrocannabinol (THC): A Randomized Crossover Trial
62
Yui, K.; Ikemoto, S.; Goto, K.; Nishijima, K.; Yoshino, T.; Ishiguro, T.: Spontaneous Recurrence of Methamphetamine-lnduced Paranoid-Hallucinatory States in Female Subjects: Susceptibility to Psychotic States and Implications for Relapse of Schizophrenia

Case Report

72
Scheschonka, A.; Bleich, St.; Buchwald, A. B.; Ruther, E.; Wiltfang, J.: Development of Obsessive-Compulsive Behaviour Following Cortisone Treatment
75
Pezawas, L.; Stamenkovic, M.; Aschauer, N.; Moffat, R.; Kasper, S.: Successful Treatment of Recurrent Brief Depression with Reboxetine - A Single Case Analysis
77
Haberfellner, E. M.: Sexual Dysfunction Caused by Reboxetine
79
Heinze, M.; Andreae, D.; Grohmann, R.: Rivastigmin and Impaired Motor Function

Letter to the Editor

81
Engfer, A.: Soyka M, Bottlender R, Möller H-J;
Epidemiological Evidence for a
Low Abuse Potential of Zolpidem; Pharmacopsychiatry 2000, 33:
138 - 141
81
Author's reply